Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

CUSIP: 92915B106

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
55,632,823
Total 13F shares
11,312,957
Share change
+364,226
Total reported value
$232,911,475
Price per share
$20.59
Number of holders
74
Value change
+$24,126,972
Number of buys
55
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 92915B106?
CUSIP 92915B106 identifies VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2017

As of 30 Sep 2017, Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,312,957 shares. The largest 10 holders included FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Casdin Capital, LLC, VANGUARD GROUP INC, BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, Partner Fund Management, L.P., WELLS FARGO & COMPANY/MN, CITADEL ADVISORS LLC, and BAKER BROS. ADVISORS LP. This page lists 74 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.